JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2025 ,inter alia, to consider and approve Audited Financials ....
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories has informed the exchanges that its Board of Directors will meet on Saturday, 17 May 2025 to consider and approve the Audited Financial Results (both Standalone and Consolidated) for the quarter and full year ended 31 March 2025. The filing is made under Regulation 29(1)(a) of SEBI LODR Regulations. The company's trading window for insiders has been closed since 1 April 2025 and will reopen 48 hours after the results are announced. No actual financial numbers have been disclosed in this intimation.
This is a routine pre-results intimation, so there is no direct impact on the stock. Investors should watch for the audited FY25 results announcement on or after 17 May 2025 for actual performance, dividend, or other board-level decisions.